Istinye University Faculty of Health Sciences, Physiotherapy and Rehabilitation Department
Istanbul, Turkey (Türkiye)
NCT Number: NCT06987994
This clinical trial aims to evaluate the effectiveness of virtual reality (VR) as a complementary intervention to traditional physical therapy for individuals diagnosed with Multiple Sclerosis (MS). MS is a chronic neurological condition that affects motor and cognitive functions, with fatigue being one of the most common and disabling symptoms. This study will assess whether the use of VR-based applications, in addition to standard physiotherapy, can reduce fatigue and improve functional capacity in individuals with MS.
Participants will be randomly assigned to two groups: one group will receive conventional physiotherapy only, while the other will receive VR-based therapy alongside physiotherapy. The intervention period will last four weeks, and both groups will be evaluated using standardized outcome measures before and after the intervention. These include the Fatigue Severity Scale (FSS), the Timed Up and Go (TUG) test, and the 6-Minute Walk Test (6MWT).
The study is designed to address a gap in current literature, as no prior research has specifically examined the impact of virtual reality on fatigue and functional performance in MS patients. The findings may provide valuable insights into innovative rehabilitation strategies that enhance patient outcomes and improve quality of life.
Looking for future studies?
Notify Me20 year–85 year
All sexes
Interventional
Not applicable
Istanbul, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive conventional physiotherapy 3 times per week for 4 weeks. The treatment includes:
Standing exercises: multidirectional stepping, single- and double-leg stance
Walking exercises: forward, backward, and lateral walking
Weight-shifting exercises: lunges, half-squats, leaning, and reaching
In this group the number of Participants are 15 . The experment by using VR sessions will last 30 minutes per session, 3 times per week for 4 weeks . In addition to the same physiotherapy program used in the control group, this group will receive Virtual Reality (VR) training using a Meta Quest 2 headset . Patients will interact with immersive environments designed to stimulate movement and functional tasks.
Other names: Virtual Rrality
Time frame: Baseline and after 4 weeks of intervention
Fatigue will be assessed using the Fatigue Severity Scale (FSS), a validated questionnaire consisting of 9 items scored on a 7-point Likert scale. The scale measures the impact of fatigue on daily functioning and is widely used in MS populations to evaluate changes in perceived fatigue.
Time frame: Baseline and after 4 weeks of intervention
The Timed Up and Go (TUG) test will be used to assess functional mobility and fall risk. Participants will be timed as they rise from a seated position, walk 3 meters, turn, walk back, and sit down again. The time (in seconds) required to complete the task will be recorded. TUG is a validated measure commonly used in individuals with MS to assess gait and mobility status.
Istinye University
Other
The Effect of Virtual Reality on Fatigue and Functional Capacity in Patients With Multiple Sclerosis
Acronym: VRMS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07680738
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Mexico City, Mexico
View Trial DetailsNCT07589062
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Abu Dhabi, United Arab Emirates
View Trial DetailsNCT07193823
Anxiety, Anxiety Disorders
Izmir, Bornova, Turkey (Türkiye)
View Trial DetailsNCT07514104
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Elâzığ, Turkey (Türkiye)
View Trial Details